Arcutis Biotherapeutics (ARQT) Exchange Rate Effect (2023 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Exchange Rate Effect of -$119000.0 for Q1 2026, down 3075.0% year-over-year from $4000.0 in Q1 2025, and down 301.69% quarter-over-quarter from $59000.0 in Q4 2025.
Arcutis Biotherapeutics (ARQT) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Exchange Rate Effect history runs 4 years deep, the most recent figure standing at -$119000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 3075.0% year-over-year to -$119000.0; the TTM figure through Mar 2026 stood at $45000.0 (up 128.48% YoY), while the FY2025 annual figure was $168000.0, up 171.49% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$119000.0, down from $59000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $200000.0 in Q2 2025, with the low at -$234000.0 in Q4 2024.
- The 4-year median for Exchange Rate Effect is -$26000.0 (2024), against an average of -$18153.8.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect soared 869.23% in 2025, then tumbled 3075.0% in 2026.
- Arcutis Biotherapeutics' Exchange Rate Effect stood at $68000.0 in 2023, then sank by 444.12% to -$234000.0 in 2024, then surged by 125.21% to $59000.0 in 2025, then plunged by 301.69% to -$119000.0 in 2026.
- Business Quant data shows ARQT's Exchange Rate Effect at -$119000.0 in Q1 2026, $59000.0 in Q4 2025, and -$95000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | -46,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -46,000.00 |
| Jun 30, 2026 | -46,000.00 |
| Mar 31, 2026 | -119,000.00 |
| Mar 31, 2026 | -119,000.00 |
| Dec 31, 2025 | 59,000.00 |
| Dec 31, 2025 | 59,000.00 |
| Sep 30, 2025 | -95,000.00 |
| Sep 30, 2025 | -95,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -234,000.00 |
| Dec 31, 2024 | -234,000.00 |
| Sep 30, 2024 | 98,000.00 |
| Sep 30, 2024 | 98,000.00 |
| Jun 30, 2024 | -26,000.00 |
| Jun 30, 2024 | -26,000.00 |
| Mar 31, 2024 | -73,000.00 |
| Mar 31, 2024 | -73,000.00 |